IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification

CAESAREA, Israel, July 19, 2024 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it has received a written notice…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.